Fostering a Team-Based Approach to Elevate Neuro-Oncology Care

Commentary
Video

Specialties including neurosurgery, radiation oncology, and neurorehabilitation all play a notable role in the care of patients with brain tumors.

Sylvia Kurz, MD, PhD, spoke with CancerNetwork® about the importance of collaborating with multiple disciplines to elevate the level of care and meet the needs of patients with brain tumors.

According to Kurz, an associate professor of neurology (neuro-oncology) as part of the Chênevert Family Brain Tumor Center at Smilow Cancer Hospital and Yale Cancer Center, she works with members from the neurosurgery, radiation oncology, and neurorehabilitation departments to ensure that patients regain strength and functionality for day-to-day living as they undergo treatment for their disease. Additionally, multidisciplinary collaboration includes the involvement of palliative care services, social workers, and psychological counselors, which may help patients and their loved ones cope with diagnoses and treatments.

Transcript:

It does take a village in neuro-oncology to provide good care to patients. All [types of] specialties are part of our team approach. I'd say the vast majority of my patients will see multiple specialties very early on in their illnesses. That includes neurosurgery, radiation oncology, me, and neurorehabilitation. Most of our patients will go to rehab after initial resection or if they're readmitted. It's a very common thing to send them to rehab to regain strength and functionality in daily activities.

[Regarding] palliative care, many of my patients are involved with palliative care services early on. I would also say that many neuro-oncologists feel very comfortable providing palliative care, meaning symptom-oriented care, themselves to those patients. I would also say toward the end of life that we don't rely on palliative care services to have those discussions, but we...are always part of these discussions, as we should be. Yes, we do work a lot with social workers and psychological counselors to help patients and their families cope with their diagnosis and treatments.

This is the center of what we do, and we involve multidisciplinary teams for most of our patients.

Recent Videos
Trials at scale can be conducted in middle-income, low-middle-income, and even lower-income countries if you organize a trial ecosystem.
Immunotherapy-based combinations may elicit a synergistic effect that surpasses monotherapy outcomes among patients with muscle-invasive bladder cancer.
A new partnership agreement involving AI use may help spread radiotherapeutic standards from academic centers to more patients in community-based practices.
For example, you have a belt of certain diseases or genetic disorders that you come across, such as sickle cell disease or thalassemia, that are more prevalent in these areas.
Recent findings presented at ASTRO 2025 suggest an “exciting opportunity” to expand the role of radiation oncology in different non-malignant indications.
The 3 most likely directions of radiotherapy advancements come from new technology, combinations with immunotherapy, and the incorporation of particle therapy.
Talent shortages in the manufacturing and administration of cellular therapies are problems that must be addressed at the level of each country.
Administering oral SERD-based regimens may enhance patients’ quality of life when undergoing treatment for ER-positive, HER2-negative breast cancer.
Related Content